Choi et al., 2018
- Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.
Science advances
4:eaau0731
Full text @ Sci Adv
Target | Reagent |
---|---|
ccm2 | MO1-ccm2 |
map3k2 | MO1-map3k2 |